References
- Baley J E, Kliegman R M, Fanaroff A A. Disseminated fungal infections in very-low-birth-weight infants: clinical manifestations and epidemiology. Pediatrics 1984; 73: 144–152
- Johnson D E, Thompson T R, Green T P, Ferrieri P. Systemic candidiasis in very-low-birth-weight infants (< 1500 grams). Pediatrics 1984; 73: 138–143
- Faix R G, Kovarik S M, Shaw T R, Johnson R V. Mucocutaneous and invasive candidiasis among very-low-birth-weight (< 1500 grams) infants in intensive care nurseries: A prospective study. Pediatrics 1989; 83: 101–107
- Weese-Mayer D E, Fondriest D W, Brouillette R T, Shulman S T. Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study. Pediatr Infect Dis J 1987; 6: 190–196
- Butler K M, Rench M A, Baker C J. Amphotericin B as a single agent in the treatment of systemic candidiasis in neonates. Pediatr Infect Dis J 1990; 9: 51–56
- Turner R B, Donowitz L G, Hendley J O. Consequences of candidemia for pediatric patients. Am J Dis Child 1985; 139: 178–180
- Brammer K W, Farrow P R, Faulkner J K. Pharmacokinetics and tissue penetration of fluconazole in humans. Rev Infect Dis 1990; 12(Suppl. 3)318–326
- Bunin N, Camitta B. Oral fluconazole for treatment of disseminated fungal infection. Pediatr Infect Dis J 1989; 8: 62
- Viscoli C, Castagnola E, Corsini M, Gastaldi R, Soliani M, Terragna A. Fluconazole therapy in an underweight infant. Eur J Clin Microbiol Infect Dis 1989; 8: 925–926
- Viscoli C, Castagnola E, Fioredda F, Ciravegna B, Barigione G, Terragna A. Fluconazole in the treatment of candidiasis in immunocompromised children. Antimicrob Agents Chemother 1991; 35: 365–367